Amunix: Sanofi's Pending Acquisition of Amunix
Fenwick & West advised Amunix on the deal. Amunix, an immuno-oncology company, announced its pending acquisition by Sanofi, a global biopharmaceutical company. The?acquisition will?help Sanofi accelerate its [...]
Read full article »
Amunix is a California-based biotechnology company that develops and markets T-cell and cytokine therapies for the treatment of cancer.
Read more